QuickView for alpha DNA polymerase:primase complex (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
3. Coronary artery endothelial cells treated with anti-tumor agent sparstolonin B
4. Primary and iPSC-derived neural progenitor cells; timecourse differentiation
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

1. Localization of proteins that are coordinately expressed with Cln2 during the cell cycle.
2. Dissociation and reconstitution of a DNA polymerase alpha-primase complex.
3. Purification and characterization of two forms of DNA polymerase alpha from mouse FM3A cells: a DNA …
4. A DNA polymerase alpha catalytic subunit is purified independently from the tissues at meiotic prome…
5. A novel stimulating protein of mammalian DNA polymerase alpha.

There were no clinical trials for alpha DNA polymerase:primase complex